IN2012DN03631A - - Google Patents

Download PDF

Info

Publication number
IN2012DN03631A
IN2012DN03631A IN3631DEN2012A IN2012DN03631A IN 2012DN03631 A IN2012DN03631 A IN 2012DN03631A IN 3631DEN2012 A IN3631DEN2012 A IN 3631DEN2012A IN 2012DN03631 A IN2012DN03631 A IN 2012DN03631A
Authority
IN
India
Prior art keywords
canines
eye
carotenes
amounts
maladies
Prior art date
Application number
Other languages
English (en)
Inventor
Yuanlong Pan
Wei Wang
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of IN2012DN03631A publication Critical patent/IN2012DN03631A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/01Hydrocarbons
    • A61K31/015Hydrocarbons carbocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IN3631DEN2012 2009-10-30 2010-10-22 IN2012DN03631A (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28017509P 2009-10-30 2009-10-30
PCT/US2010/002815 WO2011059474A1 (en) 2009-10-30 2010-10-22 Methods for maintaining eye health and ameliorating opthalmic maladies in canines

Publications (1)

Publication Number Publication Date
IN2012DN03631A true IN2012DN03631A (pl) 2015-06-26

Family

ID=43991896

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3631DEN2012 IN2012DN03631A (pl) 2009-10-30 2010-10-22

Country Status (12)

Country Link
US (1) US20120270954A1 (pl)
EP (1) EP2493293B1 (pl)
JP (1) JP6071554B2 (pl)
CN (1) CN102686107A (pl)
AU (1) AU2010318687B2 (pl)
BR (1) BR112012010179A2 (pl)
CA (1) CA2778229A1 (pl)
ES (1) ES2566652T3 (pl)
IN (1) IN2012DN03631A (pl)
MX (1) MX2012004777A (pl)
RU (1) RU2012122169A (pl)
WO (1) WO2011059474A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6026719B2 (ja) * 2010-08-31 2016-11-16 株式会社ダイセル 視機能予防・改善剤
WO2013043366A1 (en) * 2011-09-20 2013-03-28 Nestec S.A. Methods and compositions for improving visual function and eye health

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2094060C1 (ru) * 1994-03-22 1997-10-27 Уфимский научно-исследовательский институт глазных болезней Глазная мазь
NZ527924A (en) * 1999-01-29 2005-01-28 Mars Uk Ltd Antioxidant compositions and methods for companion animals
US20020110604A1 (en) * 2000-08-11 2002-08-15 Ashni Naturaceuticals, Inc. Composition exhibiting synergistic antioxidant activity
US20020182736A1 (en) * 2001-04-02 2002-12-05 Trustees Of Tufts College Methods to measure lipid antioxidant activity
KR20060013632A (ko) 2002-05-17 2006-02-13 오쎄라 파마슈티걸즈, 인크. 백내장 및 다른 안질환 발병의 개선
AU2003232828B2 (en) 2002-05-28 2010-06-24 Takeda Gmbh Topically applicable pharmaceutical preparation
WO2005087208A2 (en) * 2004-03-10 2005-09-22 Trustees Of Tufts College Synergistic effect of compositions comprising carotenoids selected from lutein, beta-carotene and lycopene
EP1778207A2 (en) * 2004-08-18 2007-05-02 Sytera Inc. Combination compositions comprising 13-cis-retinyl derivatives and uses thereof to treat opthalmic disorders
WO2006116755A2 (en) * 2005-04-28 2006-11-02 Trustees Of Tufts College Synergitic effects of docosahexaenoic acid (dha) and carotenoid absorption of cognitive function
ES2751020T3 (es) * 2006-06-08 2020-03-30 Iams Europe B V Composición para mejorar la salud ocular
US8158667B2 (en) 2006-08-21 2012-04-17 Kador Peter F Topical treatment of cataracts in dogs
CA2702885A1 (en) 2007-10-19 2009-04-23 R-Tech Ueno, Ltd. Pharmaceutical composition for treatment of cataract
US20090196921A1 (en) * 2008-02-06 2009-08-06 The Procter & Gamble Company Compositions Methods and Kits For Enhancing Immune Response To A Respiratory Condition

Also Published As

Publication number Publication date
ES2566652T3 (es) 2016-04-14
MX2012004777A (es) 2012-06-01
WO2011059474A1 (en) 2011-05-19
US20120270954A1 (en) 2012-10-25
JP2013509407A (ja) 2013-03-14
BR112012010179A2 (pt) 2015-09-29
AU2010318687A1 (en) 2012-05-24
CA2778229A1 (en) 2011-05-19
EP2493293B1 (en) 2016-03-02
EP2493293A1 (en) 2012-09-05
EP2493293A4 (en) 2013-03-20
RU2012122169A (ru) 2013-12-10
AU2010318687B2 (en) 2016-02-25
JP6071554B2 (ja) 2017-02-01
CN102686107A (zh) 2012-09-19

Similar Documents

Publication Publication Date Title
MX350951B (es) Composiciones y metodos para tratar enfermedades retinales.
MY151018A (en) Use of nutritional compositions for preventing disorders
MY176679A (en) Use of nutritional compositions for preventing disorders
PH12018500401B1 (en) Antibodies specific for tgf-beta
ECSP099516A (es) Composición suplementaria nutricional para el tratamiento de enfermedades oculares
MX2019004468A (es) Uso de lentes de contacto en el tratamiento de una afeccion oftalmologica.
WO2010105728A3 (en) Active retinal implant
PL2262476T3 (pl) Dostarczanie leku do przedniego i tylnego odcinka oka z użyciem kropli do oczu
WO2007136518A3 (en) Treatment of autoimmune disorders
SG156649A1 (en) Crig polypeptide for prevention and treatment of complement-associated disorders
MX2007010752A (es) Usos oftalmicos de moduladores de receptor s1p.
WO2011151685A8 (en) N-acetyl-dl-leucine, neuroprotective and retinoprotective medicament
TN2010000566A1 (en) Folic acid - ramipril combination : cell protective neuroprotective and retinoprotective ophtalmologic drugs
WO2007135426A3 (en) Treatment of neurodegeneratives diseases
IN2012DN03631A (pl)
HK1077306A1 (en) Ocular gene therapy
Kim Hyaluronic acid
Clarke Non-arteritic anterior ischaemic optic neuropathy: case report
Law Intracranial hypertension: case report
De Rojas Bilateral choroidal effusion: case report
WO2013130672A3 (en) Improved cancer treatments and diagnostics
Santos-Bueso Sodium aurothiomalate
RU2016131144A (ru) Способы облегчения глазных болезней у псовых
Bahali Mydriasis: case report
Khursheed Stevens-Johnson syndrome leading to irreversible bilateral damage to cornea: case report